-transparent.png){kind=logo}
Two cases with acute reversible renal failure while receiving sulfinpyrazone after acute myocardial infarction are presented. Sulfinpyrazone 200 mg q.i.d. was started a few days after the myocardial infarction. In both patients BUN and creatinine rose significantly, and returned to previous values when the drug was discontinued. No other known causes of renal failure were present in either of the patients.
Related Publications
S Keidar, and
R Kohan, and
J Levy, and
E Grenadier, and
A Palant, and
J Ben Ari
January 1983,
Clinical nephrology,
S Keidar, and
R Kohan, and
J Levy, and
E Grenadier, and
A Palant, and
J Ben Ari
March 1986,
Klinische Wochenschrift,
S Keidar, and
R Kohan, and
J Levy, and
E Grenadier, and
A Palant, and
J Ben Ari
September 1983,
Clinical nephrology,
S Keidar, and
R Kohan, and
J Levy, and
E Grenadier, and
A Palant, and
J Ben Ari
January 1988,
Acta medica Scandinavica,
S Keidar, and
R Kohan, and
J Levy, and
E Grenadier, and
A Palant, and
J Ben Ari
July 1992,
Indian journal of medical sciences,
S Keidar, and
R Kohan, and
J Levy, and
E Grenadier, and
A Palant, and
J Ben Ari
January 1984,
Revista chilena de pediatria,
S Keidar, and
R Kohan, and
J Levy, and
E Grenadier, and
A Palant, and
J Ben Ari
April 1997,
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
S Keidar, and
R Kohan, and
J Levy, and
E Grenadier, and
A Palant, and
J Ben Ari
January 1984,
Nephron,
S Keidar, and
R Kohan, and
J Levy, and
E Grenadier, and
A Palant, and
J Ben Ari
March 1998,
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
S Keidar, and
R Kohan, and
J Levy, and
E Grenadier, and
A Palant, and
J Ben Ari
July 1983,
Clinical nephrology,
